Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 15 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; sodium citrate dihydrate; magnesium stearate; gelatin; titanium dioxide; sunset yellow fcf; brilliant blue fcf; quinoline yellow - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 7.5 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; sodium citrate dihydrate; magnesium stearate; gelatin; titanium dioxide; sunset yellow fcf; brilliant blue fcf - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - meloxicam, quantity: 15 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; sodium citrate dihydrate; magnesium stearate; gelatin; titanium dioxide; sunset yellow fcf; brilliant blue fcf; quinoline yellow - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - meloxicam, quantity: 7.5 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; sodium citrate dihydrate; magnesium stearate; gelatin; titanium dioxide; sunset yellow fcf; brilliant blue fcf - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - meloxicam, quantity: 15 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; maize starch; sodium citrate dihydrate; colloidal anhydrous silica; magnesium stearate - meloxicam-dp is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; maize starch; sodium citrate dihydrate; colloidal anhydrous silica; magnesium stearate - meloxicam-dp is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

4 life research pty ltd - bovine colostrum powder -

Australia - English - Department of Health (Therapeutic Goods Administration)

4 life research pty ltd - aloe vera,avena sativa,bovine colostrum powder,conifer phytosterol complex,cordyceps sinensis,ganoderma lucidum,lentinula edodes,olea europaea,oryza sativa,saccharomyces cerevisiae,zinc amino acid chelate -

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - carbimazole, quantity: 5 mg - tablet, multilayer - excipient ingredients: lactose monohydrate; sucrose; acacia; maize starch; purified talc; magnesium stearate; gelatin; iron oxide red - therapy of hyperthyroidism. definitive therapy: induction of a permanent remission, in either primary or secondary thyrotoxicosis. preparation for thyroidectomy. before and after radioactive iodine treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - carbimazole 5mg;  ; carbimazole 5mg - tablet - 5 mg - active: carbimazole 5mg   excipient: acacia gelatin iron oxide red lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propyl hydroxybenzoate purified talc sucrose active: carbimazole 5mg excipient: acacia gelatin iron oxide red lactose monohydrate magnesium stearate maize starch purified talc sucrose - primary thyrotoxicosis, even in pregnancy. secondary thyrotoxicosis - toxic nodular goitre. however, neo-mercazole really has three principal applications in the therapy of hyperthyroidism: 1. definitive therapy - induction of a permanent remission. 2. preparation for thyroidectomy. 3. before and after radio-active iodine treatment.